ABSTRACT Background: The β2-adrenergic receptor gene (ADRB2) is a target molecule of β2-agonists. Single nucleotide polymorphisms (SNPs) in the ADRB2 are related to the effectiveness of β2-agonists. However, there are some discrepancies in the results of pharmacogenetic studies of ADRB2 among different ethnic groups. The aims of this study were to determine the ADRB2 haplotypes and diplotypes in Japanese asthmatic and nonasthmatic subjects and to examine their relation to asthma and to compare these results with previous studies done in other ethnic groups.
INTRODUCTION
With the completion of the Human Genome Project, the role of genomic variations in disease acquisition has become easier to define. Recently, single nucleotide polymorphisms ( SNPs ) have been favored as more tractable genotypic markers , and have been utilized extensively in human genetic studies ranging from comparative population variation to pharmacogenomics. Such SNPs have been reported to modulate pharmacodynamic reactions in individuals on exposure to drugs. [1] [2] [3] More recently, the grouping and interaction of several SNPs in haplotypes has been recognized as more important than individual SNPs for pharmacogenomic studies. The identified haplotypes for the mu opioid receptor gene (OPRM1) were associated with heroin and cocaine dependence. 4 In another study, the interaction of multiple SNPs within a haplotype of the β 2-adrenergic receptor gene (ADRB2) was reported to correlate with individual responses to β2-stimulants, whereas no correlation was found with individual SNPs. 5 Cl e a v e d n uc l e o t i d e S NP s E n z y me A n n e a l i n g t e mp e r a t u r e
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gion and 10 in the 5 ' promoter region have so far been reported to be associated with asthma severity. 8, 9 No evidence of linkage to qualitative measures of asthma and other respiratory diseases was seen at the SNPs of codon 16 or 27, [10] [11] [12] although there have been no previous reports of haplotype relevance to asthma etiology. We previously performed a prospective study with Japanese asthmatic subjects and reported that the Gly16! Gly16 genotype is related to the adverse responses during β2-agonist regular-use in Japanese asthmatics. 13 On the contrary , a recent relatively large prospective study has suggested that adverse effects of regular inhalational therapy with β 2-agonist occur in Caucasian asthmatic subjects with the Arg16! Arg16 genotype. 14 The ultimate value of SNPs for linkage and association-mapping studies depends, in part, on the distribution of SNP allele frequencies and intermarker linkage disequilibrium ( LD ) across populations. 15 In the field of drug metabolism, many SNPs have been identified that differ in frequency among different ethnic groups. 16 Numerous studies have indicated that the distribution of haplotype frequencies and LD might vary substantially among different populations. [15] [16] [17] It is therefore apparent that further evaluation of the role of ADRB2 haplotypes in asthma pathogenesis and drug response requires the investigation of haplotypes in each ethnic group.
The aims of the present study were as follows: first, to identify novel SNPs ; second , to determine the ADRB2 haplotypes and diplotypes in Japanese asthmatic and non-asthmatic subjects using molecularbased techniques; and third, to determine whether these haplotypes and diplotypes contribute to individual differences in susceptibility to asthma . We also compared the frequencies of the ADRB2 haplotypes and diplotypes between Japanese and other ethnic groups to evaluate the differences in distribution of ADRB2 SNPs.
METHODS

SUBJECTS
Forty-eight subjects with bronchial asthma were recruited from the pulmonary clinic at the Fukushima Medical University hospital, according to the following criteria. First, the presence of at least two of the following symptoms: recurrent cough, wheezing or dyspnea. Second, increased airway responsiveness to methacholine or the presence of reversible airflow limitation; the latter refers to 15% variability in the forced expiratory volume during 1 s (FEV1), or in the peak expiratory flow rate with or without an inhaled short-acting β2-agonist. The third criterion was the absence of any other pulmonary disease.
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Non-asthmatic blood samples were collected from 100 healthy Japanese subjects with no symptoms or history of allergic diseases . All of the participants gave informed consent. The ethical committees of the Fukushima Medical University , Japan , and the Otsuka Pharmaceutical Co., Ltd., Japan, approved this study.
Genomic DNA was extracted from the peripheral whole-blood leukocytes using the PUREGENE TM Blood Kit (Gentra Systems Inc. , Minneapolis, MN, USA).
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IDENTIFICATION OF NOVEL SNPS
A 2973 base pair ( bp) fragment of the ADRB 2 promoter, up to the coding region, was PCR amplified from 24 non-asthmatic subjects using the following primer pair: 5'-AGATCTCTAGAGGTTCAAGAGATTCTCCTG-3' and 5 ' -AGATCAAGCT-TTGCCCTTCCTTCTGCATATC-3'. PCR products were sequenced using dye terminator chemistry (BigDye TM , Applied Biosystems, Foster City, CA, USA) and the ABI PRISM ! 3700 DNA Analyzer (Applied Biosystems, Foster, CA, USA). Sequencing primers were designed to provide overlapping 500 bp sequences. The sequence data were assembled with Sequencher TM software ( Gene Codes Corporation, Ann Arbor, MI, USA) to identify novel SNPs.
MOLECULAR-BASED HAPLOTYPE ANALYSIS
Two approaches were used to obtain unphased and phased genotypes of the ADRB 2 gene . Unphased genotypes from both parental alleles were determined by directly sequencing polymerase-chainreaction (PCR) products amplified with the primers described above. The PCR-RFLP method was used if direct sequencing could not generate genotypes. The PCR reactions for restriction-fragment-lengthpolymorphisms (RFLP) were performed as follows: initial denaturation at 94" for 2 minutes, followed by 35 cycles of amplification at 94" for 30 seconds, annealing for 30 seconds and extension for 2 minutes. Conditions of the PCR-RFLP analysis are shown in Table 1 . RFLP assays were designed with mismatched primers that generate restriction sites. 18 Between 2 and 5 µl of the PCR products was digested overnight with 1!3 units of enzyme per reaction in a total volume of 10 µl, according to the manufacturers instructions . Digested products were separated on 2.5 ! 5% agarose gels ( Nakaraiteck BioProducts , Osaka, Japan) and visualized by staining with ethidium bromide. Phased ADRB2 genotypes were determined by digesting PCR products with XbaI and HindIII, and cloning into pBluescript ! II vector (Stratagene, La Jolla, CA, USA). After transformation of Escherichia coli JM109 Electro-Cells TM (Takara Bio Inc., Shiga, Japan), a single colony representing the sequence from one chromosome was isolated and sequenced as described above. The difference between the genomic and the cloned sequences provided the phased genotypes for both chromosomes.
RESULTS
IDENTIFICATION OF A NOVEL SNP
We used PCR direct sequencing of genomic DNA from 24 non-asthmatics to identify a novel SNP in the promoter region ( − 839 ) . This SNP conformed to Hardy-Weinberg equilibrium ( HWE ) and had not been deposited in the dbSNP database of the National Center for Biotechnology Information (NCBI).
UNPHASED SNP ANALYSIS
To ascertain the haplotypes of ADRB 2 in Japanese populations , we first analyzed the unphased genotypes of 46 asthmatic and 100 non-asthmatic subjects using direct sequencing of PCR products and a PCR restriction-fragment length polymorphism ( RFLP ) method. Table 2 shows the localization of SNPs and identification of ADRB 2 genotypes in the Japanese population. SNPs at −709, −406, 100, 491 and 1,098 were found not to be polymorphic in the Japanese population. Among the polymorphic SNPs, no significant difference was observed in allele and genotype frequencies between non-asthmatic and asthmatic subjects.
MOLECULAR-BASED HAPLOTYPE STUDIES
ADRB 2 haplotypes were determined by comparing PCR-amplified sequences of 3 kb promoter region with sequences of cloned fragments . Of the 2 20 Haplotype Analysis of ADRB2 in Japanese Allergology International Vol 55, No2, 2006 www.jsaweb.jp! Ca u c a s i a n s J a p a n e s e Di p l o t y p e s F r e q u e n c y F r e q u e n c y N 0 . 8
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e n J a p a n e s e a n d Ca u c a s i a n s ( 1,048,576 ) possible combinations of these SNPs , only 42 haplotypes and 54 diplotypes were found to exist in the Japanese population (Tables 3,5 ). To determine whether there were any haplotypes associated with asthma, we performed a Chi square test between asthmatics and non-asthmatics. Haplotype distributions were not significantly different between these two groups.
HAPLOTYPES AND DIPLOTYPES IN DIFFERENT ETHNIC GROUPS
To compare the distribution of ADRB 2 haplotypes among different ethnic groups , we reorganized the haplotypes using 13 SNPs that were analyzed by Drysdale et al.. 5 We identified 17 haplotypes and 23 diplotypes in the Japanese population , whereas 12 haplotypes and 18 diplotypes were reported in Caucasians. Furthermore, there were extreme differences in allele frequencies between Japanese and Caucasians (Table 4) . Haplotype 2, which was the most frequent in Caucasians (48.3%), was only present in 7.9% of the Japanese population. By contrast, haplotype 6, which was the most frequent in Japanese (35.6%) together with haplotype 4, was only present in 13.2% of Caucasians. Diplotype 2! 4, which was the most frequent in Caucasians (30.6%), was seen in only 6.2% of the Japanese population. By contrast, diplotype 6! 6, which was the most frequent in Japanese (18.5%), was absent in Caucasians (Table 5 ). To address the question of why haplotype frequencies were so different between Japanese and Caucasians, linkage disequilibrium (LD) in Japanese was quantitated, as described by Hill and Weir. 19 Its pattern in the Japanese population seemed to be similar to those of Caucasians, except for the SNP at position −1,023. This SNP showed strong LD to −468, −367, −47 and −20 in Caucasians, 5 but showed only weak LD in Japanese (Fig. 1) .
HARDY-WEINBERG EQUILIBRIUM AND NU-CLEOTIDE DIVERSITY
All SNPs, except for +1239T! G , and all haplotypes were found to conform to HWE. Within ADRB2, the observed frequencies at + 1239 T ! G in the nonasthmatic sample group deviated from the expected values (p = 0.021). However, when the test was performed with Bonferroni's correction to adjust for multiple comparisons, none of the allele frequencies in the non-asthmatic group deviated from HWE.
DISCUSSION
Many chromosome loci have been reported to be associated with asthma and atopy, including 5q, 6p, 11q 12q and 17p. 20, 21 ADRB2, which is localized at 5q31! q32, has been extensively studied as a candidate gene for asthma and atopy. 22 Allele frequencies of ADRB2 polymorphisms have been reported to differ among ethnic groups. 23 In the present study, we examined the frequencies of allele, genotypes, haplotypes and diplotypes of ADRB 2, which were analyzed in 100 non-asthmatic and 46 asthmatic Japanese subjects . No significant differences were detected in the frequencies of each SNP between asthmatic and nonasthmatic groups ( Chi square test) . No association was observed between ADRB 2 haplotypes and asthma ( Chi square test , p = 0.094 ! 0.227 ) , in 42 haplotypes constructed with 15 SNPs on 292 chromosomes (Table 3) . Therefore, we combined both the F i g . 1 L i n k a g e d i s e q u i l i b r i u m b e t we e n A DRB2 S NP s . Ge n o t y p e s f r o m t h e J a p a n e s e s a mp l e s we r e d e t e r mi n e d a t t h e 1 5 l o c i s h o wn i n T a b l e 3 , a n d t h e d e g r e e o f l i n k a g e d i s eq u i l i b r i u m ( r 2 ) b e t we e n S NP s wa s c a l c u l a t e d u s i n g S NP A n a l y z e r s o f t wa r e ( Dy n a c o m Co . , L t d . , Ch i b a , J a p a n ) . frequencies of asthmatic and non-asthmatic subjects for haplotypes and diplotypes for a comparative ethnic study . ADRB 2 allele frequencies and genotype distributions in African Americans were similar to those in Japanese . Evans et al . 23 suggested that ADRB2 codon 16 and 27 frequencies (SNP positions 46 and 79 in Tables 1,2 ) fall into two clusters of Caucasians and African-Chinese. Other investigations included Japanese and Egyptians with the AfricanChinese cluster. 24 The frequencies of Japanese in the present study were similar to those of AfricanChinese previously reported . 23, 24 In the present study, the high frequencies of haplotypes 1, 2, 4 and 6 (Table 4 ) support the inclusion of Japanese in the African-Chinese cluster, which was also observed to have high frequencies of haplotypes 1, 2, 4 and 6 compared with Caucasians. 23 It is of interest that approximately 70% of haplotypes were shared between the Japanese and Caucasians , whereas only 30% of the diplotypes were shared (Tables 4,5 ). From these results it can be suggested that Caucasians have a unique distribution of ADRB2 SNPs. In addition, a recent relatively large prospective study has suggested that adverse effects of regular inhalational therapy with β2-agonist occur in Caucasian asthmatic subjects with the Arg! Arg genotype at aminoacid residue 16. 14 In contrast, our previous prospective study revealed opposite results indicating that the Gly! Gly genotype is related to adverse effects of β2-agonist regular use in Japanese asthmatics. 13 The results of the present study revealed that, a major part of Caucasian subjects with the Arg16 genotype (A allele in nucleotide 46) belong to haplotype 2 (48.3%) and 4 (33.0%). By contrast, Japanese subjects with the same genotype belong to haplotype 4 (36%) and 6 (35.6%). In this context, more than half of the Japanese subjects with the Arg 16 genotype belong to the different haplotype when compared to Caucasian. We identified a new diplotype ( 6 ! 6 ) , which occurred most frequently in Japanese subjects (18.5%) and was not seen in Caucasians (Table 5 ). An association study between the ADRB 2 haplotype and β 2-stimulant response in Caucasian populations suggested that patients sensitive to the β2-stimulant have diplotype 4! 6 rather than 4! 4. 5 It is therefore of interest to assess any increased sensitivity to the β 2-stimulants in patients with the 6! 6 diplotype, which might be useful for association studies between the ADRB 2 haplotype and bronchodilator responses to the β2-stimulants.
From these results, we conclude that ADRB2 may be involved in the pharmacogenetics of asthma , rather than contributing to the pathogenesis, in the absence of an association between ADRB2 polymorphisms and asthma. Our data on ADRB 2 haplotype analysis in the Japanese population might be useful for future pharmacogenomic studies on β2-stimulant responsiveness, and provide a better understanding of ethnic and individual differences in drug responses, which could contribute to the individualization of drug therapy.
